AAJ News Brief for Haytham Faraj | Wednesday, May 5, 2010 |
|
|
Leading the News
White House vows to work "overtime" to mitigate spill's damage.
Under the headline "White House In PR 'Panic' Over Spill," Politico
(5/5, Thrush, Allen) reports the oil spill is "threatening" the President's
"reputation for competence. ... So White House aides are escalating their
efforts to reassure Congress and the public in the face of a slow-motion
catastrophe, even though it's not clear they can bring it under control anytime
soon." One senior Administration official said, "There is no good answer to
this. ... There is no readily apparent solution besides one that could take
three months. ... If it doesn't show the impotence of the government, it shows
the limits of the government." The story continues later that "the promise of
rational, responsive and efficient government is Obama's brand, his
justification for bigger and bolder federal interventions," so, according to an
Administration official, "there was a 'little bit of panic'...when White House
aides sensed the oil spill narrative getting away from them last
week."
Administration supports efforts to lift damages cap retroactively.
Meanwhile, the AP
(5/5, Daly, Werner) reports, "the White House is pushing to lift the limit on
how much BP pays" for the spill, as "Press Secretary Robert Gibbs said Tuesday
the administration wants to work with Congress to change a law that caps at $75
million BP's liability for economic damages like lost wages or dwindling tourist
dollars." Currently, Sen. Robert Menendez (D-NJ) "is co-sponsoring a measure
that would raise the liability limit to $10 billion," which he wants "to be made
retroactive so it can apply" to the BP spill. Gibbs said that the
Administration "supported Menendez's attempts to raise the limit retroactively,"
while noting that "if BP is found to have acted negligently or violated the law,
the cap would not be in
effect."
BP's oil rig exempted from environmental impact analysis.
According to government documents, the Washington
Post (5/5, Eilperin) reports, the Interior Department's Minerals
Management Service "exempted BP's calamitous Gulf of Mexico drilling operation
from a detailed environmental impact analysis last year...after three reviews of
the area concluded that a massive oil spill was unlikely." The agency's
decision "to give BP's lease at Deepwater Horizon a 'categorical exclusion' from
the National Environmental Policy Act (NEPA) on April 6, 2009 -- and BP's
lobbying efforts just 11 days before the explosion to expand those exemptions --
show that neither federal regulators nor the company anticipated an accident of
the scale of the one unfolding in the gulf." And have lead environmentalists
and some key senators to call "for a reassessment of safety requirements for
offshore
drilling."
BP plans to drop dome over well as cleanup continues.
The CBS Evening News (5/4, story 5, 3:10, Couric) reported, "BP's chief
executive said today workers may be able to stop most of the oil leak by early
next week. They plan to drop a concrete dome over the blown-out undersea well.
For now, there's nothing to stop the flow of oil that's closing in on the gulf
coast." CBS later added, "This oily blob now sprawls across 2,000 square miles,
1400 square miles smaller than last week. As chunks of it break away. And
landfall is still not projected for the next three days." ABC World News
(5/4, story 7, 2:05, Sawyer) reported, "BP says it has not found any oil that
has come ashore yet, but from the sky today, our helicopters saw clear signs of
oil ashore on the southern tip of the Mississippi Delta. Most of the oil still
at sea and the weather calming, officials are scrambling to contain it." Rear
Adm. Mary Landry, US Coast Guard, said, "We do have a gift of time. A little
bit of time. But I'm not – I'm not
resting."
NBC Nightly News (5/4, story 7, 2:15, Williams) reported, "For the people
working on the water there was a nice break today from the weather. The wind
and waves diminished, meaning more people could go out to try to stop the oil.
Today Coast Guard skimmers were also back on the water collecting oil, as BP
promised to have a container dome designed to cover the main oil leak installed
over the weekend to funnel the oil out to a container
ship."
However, the New York
Times (5/5, Broder, Robertson, Krauss) reports, a senior BP executive
conceded in a closed-door briefing for members of Congress "that the ruptured
oil well in the Gulf of Mexico could conceivably spill as much as 60,000 barrels
a day of oil, more than 10 times the estimate of the current flow." And
although the company faces "a crisis similar to what the Toyota Motor Company
had with uncontrolled acceleration," it has rejected the idea of a broad
advertising campaign, with BP spokesman Andrew Gowers explaining, "In our view,
the big glossy expressions of regret don't have a lot of
credibility."
Suit says oil rig workers stranded at sea.
The AP
(5/4) reported, "Three workers forced to escape on lifeboats after an explosion
aboard an offshore drilling platform claimed in a lawsuit Tuesday that they were
kept floating at sea for more than 10 hours while the rig burned
uncontrollably." The lawsuit, "filed in county court in Galveston, Texas, seeks
unspecified damages on behalf of rig workers Joshua Kritzer, Bill Johnson and
Nick Watson, all from Louisiana; and the family of Aaron Dale Burkeen of
Mississippi, one of 11 workers missing and presumed dead following the April 20
explosion."
Property owners may seek to recover losses.
Bloomberg
News (5/4, Gittelsohn, Brandt) reported, "Lawsuits are one avenue real
estate owners may use to recover losses tied to the oil spill, said Robert
Hartwig, president and economist for the Insurance Information Institute, an
industry research center in New York." Robert Cunningham of Cunningham Bounds
LLC in Mobile, Alabama, which has "filed suits on behalf of fishermen and
property owners in federal courts in Florida and Alabama," said, "There are
questions of diminution of value, clean-up costs and all kinds of issues for the
population and condo
owners."
Transocean had concerns over safety.
The AP
(5/4) reported, "Transocean Ltd., which owned the drilling rig that exploded in
the Gulf of Mexico, eliminated bonuses for top executives last year over
concerns about safety problems at the company. The company said in a regulatory
filing on April 1 that it eliminated the bonuses 'to underscore the company's
commitment to safety' after four workers died in accidents in 2009 'and to
increase the incentive for executive officers to promote ... the avoidance of
future fatal accidents.' Less than three weeks later, the company's Deepwater
Horizon rig, which it leased to BP PLC, blew up and
sank."
From the American Association for
Justice |
With rapidly evolving changes in
the diagnosis, treatment, and rehabilitation of TBI survivors, you'll need AAJ
Education's Litigating Traumatic Brain Injury Cases Seminar, May 20-21 in
Chicago, IL, to successfully prosecute your clients' cases. Our faculty of
experienced trial lawyers and experts will provide a clear path on how to handle
your next TBI case. To view the agenda and register, visit Continuing Legal Education. The AAJ Exchange's
Voir Dire and Jury Selection Litigation Packet provides plaintiff
attorneys with valuable tools to meet the challenge of selecting an impartial
jury. The packet contains hundreds of sample voir dire questions covering all
types of case, from products liability to medical negligence to automobile
collisions. The packet also includes tools and techniques for expanding voir
dire, strategies and tactics for the use of peremptories and challenges for
cause, and an analysis of juror decision making. To order or view the table of
contents for the more than 130 Packets, visit the AAJ Exchange. The Motor Vehicle Collision,
Highway and Premises Liability Section focuses on auto collision cases,
truck safety, highway design, and premises liability. The Section also provides
discussion of federal no-fault issues. In addition, the Section offers a list
server, quarterly newsletter, networking, referral opportunities, and much more.
To learn about our 18 Sections and join, visit Sections. |
|
|
AAJ in the News
Lipsen succeeds Henderson as AAJ CEO.
In continuing coverage, CongressDaily
(5/4) reported, "The American Association for Justice has promoted Linda Lipsen
from executive vice president for public affairs to chief executive officer. She
succeeds CEO Tom Henderson, who held the position on an interim basis for a
year. Since 1993, Lipsen has led the advocacy and lobbying team at AAJ, formerly
known as the Association of Trial Lawyers of
America."
Politico
(5/5, Milfeld, Lee) reports, "At the helm, Lipsen will continue the
association's long fight to promote the accessibility of the U.S. civil justice
system against efforts to limit it. 'Linda's commitment to representing and
advocating for injured patients, workers and consumers has been the bedrock of
AAJ's mission for many years,' said AAJ President Anthony
Tarricone."
Simmons announces settlement of antitrust lawsuit.
In a press
release (5/3), Simmons Browder Gianaris Angelides & Barnerd LLC wrote,
"Simmons Browder Gianaris Angelides & Barnerd LLC of East Alton, Ill., today
announced the resolution of their client Synergetics USA, Inc.'s (Nasdaq: SURG)
antitrust lawsuit pending against Alcon Laboratories, Inc., and Alcon, Inc.
Synergetics announced on April 27, 2010, that it had entered into a Settlement
and Licensing Agreement and a Supply Agreement with Alcon, pursuant to which all
litigation between the companies would be settled and Alcon would receive a
license to sell certain Synergetics-patented products. Alcon will pay
Synergetics $32 million in the arrangement." In "a unique approach to
commercial litigation," Simmons "took on the high-risk litigation under a
contingency fee arrangement, whereby Synergetics would pay attorneys' fees only
as a percentage of any recovery in the case." Derek Brandt, "the Simmons firm
partner who spearheaded the firm's efforts in the case," said, "Our willingness
to take the case on a contingency basis meant that a relatively small company
like Synergetics could pursue a high-stakes litigation against an infinitely
larger competitor. We shared the risk with our client and reached a very
gratifying
result."
Civil Justice System
New York homeowners sue Chase over loan modifications.
Crain's
New York Business (5/4, Fung) reported, "Three Queens homeowners filed
a lawsuit against J.P. Morgan Chase Bank N.A. and two of its subsidiaries, Chase
Home Finance and Washington Mutual Bank, claiming that the groups illegally
delayed and denied their applications for permanent foreclosure relief under the
federal Home Affordable Modification Program. The lawsuit is seen as one of the
first cases involving the modification program in New York City. The lawsuit,
which was filed in the Eastern District Federal Court in Brooklyn, claims that
the bank violated the federal program that requires banks to provide permanent
modifications to eligible homeowners who complete three months of trial payments
and verify their
income."
The Wall
Street Journal (5/5, Hagerty) reports that plaintiffs allege they were
misled about their chances of obtaining long-term loan
modifications.
Los Angeles Archdiocese yet to disclose allegedly abusive priests' personnel files.
In the "L.A. Now" blog at the Los
Angeles Times (5/4), Victoria Kim wrote, "Three years after Los Angeles
Archdiocese agreed to the largest priest abuse settlement in U.S. history, a key
element of that agreement - public release of accused priests' personnel files -
remains unfulfilled with no clear outlook on when the documents may be
disclosed. For many who believed that church authorities had ignored or
downplayed their accounts of abuse, release of the documents rivaled monetary
compensation as the central part of the $660-million settlement agreement in
2007." In Los Angeles, "the throng of plaintiffs' attorneys once involved in
the cases has been reduced to just one still working on the release of the files
at the
moment."
Class-action status sought for Delaware victims of alleged pedophile pediatrician.
The Wilmington
News Journal (4/5, Barrish) reports, "Lawyers who have filed lawsuits
against alleged pedophile pediatrician Earl B. Bradley and other defendants,
including Beebe Medical Center and the Medical Society of Delaware, are now
seeking class-action status for their cases and those of other possible victims.
Attorneys Bruce L. Hudson, Ben T. Castle and Craig A. Karsnitz made the request
in a lawsuit filed late Monday on behalf of Jane Doe 30, a 12-year-old girl
Bradley allegedly
abused."
|
|
Congress
Auto safety overhaul introduced in Senate.
The AP
(5/5, Thomas) reports that the Senate Commerce Committee "proposed a major
overhaul to the nation's auto safety requirements" that "would force car
companies to meet new safety standards and face stiff penalties for failing to
report defects," just a week after a similar bill was released by the House
Energy and Commerce Committee, "underscoring Congress' intent to bring the first
significant reforms to auto safety since the Bridgestone/Firestone Inc. tire
recalls of a decade ago." The bill includes a requirement that automobiles
"stop within a certain distance when the vehicle's engine is operating with an
open throttle," which a brake override system would meet. Cars would have to
have event data recorders that hold "at least 60 seconds prior to the crash and
15 seconds after the
accident."
The New York
Times (5/5, B5, Maynard) reports that the bill "requires a standard
governing the safety of electronic vehicle controls," and Sen. Barbara Boxer
proposal "to restrict ties between auto companies and staff members of the
National Highway Traffic Safety Administration" is part of the bill. The NHTSA
also "would establish standards on keyless ignition systems" with the goal of
"standardizing the steps a driver would take to bring a vehicle under control in
an emergency." The bill also "would provide more money for vehicle safety
investigations by the agency, even though its administrator, David L.
Strickland, has said that the agency has sufficient
financing."
The Detroit
News (5/5, Shepardson) reports that the bill "gives sweeping new power
to the National Highway Traffic Safety Administration to halt sales and
production in the event it determines a vehicle is an 'imminent danger' to the
public."
Competition fierce for lead role in Toyota litigation.
The Wall
Street Journal (5/5, A1, Searcey) reports on the fierce competition
among attorneys for the lead role in litigation against Toyota Motor Corp. The
Journal reports that attorneys are jockeying before US District Judge James
Selna, who will oversee the litigation in Santa Ana, CA. The first hearing is
scheduled for May 13, according to the
Journal.
Insurance
Sebelius urges national review of rate increase requests from WellPoint.
The Wall
Street Journal (5/5, Johnson) reports that on Tuesday, HHS Secretary
Kathleen Sebelius urged a national review of data submitted by WellPoint while
seeking insurance rate increases. The Journal says that Sebelius' action was
spurred by a recent decision on the part of WellPoint Inc. to withdraw a request
to increase rates by up to 39% for some individual policies in California.
Sebelius said, "In light of this recent finding, I urge that, to the extent you
have authority to do so, you re-examine any WellPoint rate increases in your
state. ... Even small errors can mean unaffordable premiums for policyholders."
WellPoint CEO Angela Braly has said that the rate increases are justified
because of rising hospital and drug
costs.
Activists urge California to review other requests for insurance rate increases.
The Los
Angeles Times (5/5, Helfand) reports, "After serious errors led health
insurer Anthem Blue Cross to cancel a massive increase in health insurance
premiums last week, consumer advocates are calling for a review of pending rate
hikes by other big insurers in California." Notably, Health Access California,
"a prominent healthcare advocacy group, urged the state's two insurance
regulators Tuesday to seek independent assessments of all increases in premiums
for individual policyholders and those who get insurance through small
employers." The group's executive director said, "We fear the errors in the
Anthem Blue Cross filing are not an aberration but may be the norm," and added,
"If the insurers are not even checking the math of what they are submitting to
regulators, who knows what's in these filings and what consumers are being
charged that may not be
justified?"
CVS business practices under investigation in 24 states.
Bloomberg
News (5/5, Snyder) reports, "CVS Caremark Corp., the largest US
provider of prescription drugs, said its business practices are under
investigation by 24 states," the District of Columbia and the county of Los
Angeles. CVS also "said it received a subpoena from the Office of Inspector
General within the US Department of Health and Human Services for information on
incentives for customers to transfer their prescriptions to CVS's pharmacies."
The subpoena "is related to an investigation concerning 'possible false or
otherwise improper' claims for Medicare and Medicaid payments, the chain said."
Dow
Jones Newswire (5/5, Wisenberg Brin) also covers the
story.
Drug Safety
FDA uncovers quality control problems at plant responsible for manufacturing recalled children's medicines.
The CBS Evening News (5/4, story 7, 0:30, Couric) reported, "We're
learning more tonight about last weekend's recall of children's medicine"
manufactured by a unit of Johnson & Johnson, McNeil Consumer Healthcare. The
company voluntarily "recalled 43 over the counter medications, including Tylenol
[acetaminophen] and Motrin [ibuprofen] for children and infants." Now,
according to a recently released federal report, "inspectors found more than 20
manufacturing problems at a Pennsylvania plant, which has been shut down,"
ABC World News (5/4, story 9, 0:30, Sawyer)
reported.
The report, which the FDA "sent to McNeil last Friday, before the recall, said
the company had used raw materials with known bacterial contamination to make
certain lots of infants' and children's liquid Tylenol," the New
York Times (5/5, B2, Singer) reports. "Samples of finished products
tested negative for bacteria, however, and the risk to consumers was remote,
agency officials
said."
Wyeth asks Nevada Supreme Court for new trial in hormone drugs case.
The AP
(5/4, Chereb) reported, "Wyeth Pharmaceuticals Inc. asked the Nevada Supreme
Court for a new trial over its hormone replacement drugs" Premarin (estrogens,
conjugated) and Prempro (estrogens, conjugated/medroxyprogesterone), "arguing
Monday that a Reno jury wasn't properly instructed on punitive damages before
awarding three women a multimillion-dollar judgment on claims the drugs caused
their breast cancer." An attorney representing the company "said the jury's
'premature' deliberation of punitive damages and comments about
Wyeth...executives' salaries made by the women's attorneys prejudiced jurors
against the company." However, "lawyers for the women countered that the
mistake was inadvertent and corrected by the trial
judge."
The Las
Vegas Sun (5/5, Ryan) reports that attorney Lane Heard, in arguing on
behalf of Wyeth, "said District Judge Robert Perry should have instructed jurors
to hold separate sessions to decide compensatory and punitive damages. Heard
claims it was a 'constitutional error that tainted the entire jury.'" In
addition, Heard "told the court there were 'inflammatory arguments' in closing
arguments by the plaintiffs' attorney, who referenced the salaries of top
executives at Wyeth while discussing
damages."
Novartis paying $72.5M to settle whistleblower lawsuit on cystic fibrosis drug.
The AP
(5/5) reports, "Swiss pharmaceutical company Novartis AG is paying $72.5
million to settle a whistleblower lawsuit accusing it of improperly billing
government programs for unapproved uses of a cystic fibrosis drug" called TOBI
(tobramycin inhalation solution, USP). On May 4, "the US Attorney's Office
announced the settlement...and unsealed the lawsuit filed by former employees
Robert Lalley, Courtney Davis, and William Manos in 2006." The suit's
allegations were that "biotechnology company Chiron Corp., which
Switzerland-based Novartis acquired in 2006, billed for unapproved uses of its
drug TOBI between 2001 and 2006." The South
Florida Business Journal (5/4) and the Wall
Street Journal (5/5, Solsman) also cover the
story.
FDA warns GSK about Altabax promotional materials.
Dow
Jones Newswire (5/4, Dooren) reported that in a warning
letter dated April 19, the Food and Drug Administration took issue with
promotional material produced by drugmaker GlaxoSmithKline PLC (GSK) regarding
Altabax (retapamulin) ointment, which the agency has approved to treat impetigo.
In its letter, the FDA took particular issue with a "slim jim" sales pullout
discussing the product, saying that it found it "false or misleading." The
agency disputed a claim suggested by the slim jim that Altabax can effectively
treat all strains of Staphylococcus aureus, such as MRSA, when in reality it is
approved only to treat S. aureus that is "methicillin
susceptible."
According to the Triangle
Business Journal (5/4, Gallagher), "The FDA says GSK's 'slim jim'
marketing material was false or misleading, because it 'broadens the indication
of Altabax, makes unsubstantiated superiority claims, and omits and minimizes
important risk information associated with
Altabax.'"
Reuters
(5/4, Richwine) reported that GSK has asked its sales staff not to use these
marketing materials anymore. Reuters quoted Glaxo spokeswoman Sarah Alspach as
saying, "We take the FDA's concerns seriously and are carefully reviewing FDA's
comments."
FDA warns Novartis over Gleevec promotional material.
Dow
Jones Newswire (5/5, Dooren) reports that the FDA warned Novartis AG
about material on two company-sponsored websites that promoted its cancer drug
Gleevec [imatinib mesylate] without mentioning the product by name. The agency
said Novartis did not submit the promotional material for a 30-day review by the
agency as required. In a warning letter posted to the FDA's website, the agency
stated, "These websites are concerning from a public health perspective because
they promote Gleevec for an unapproved use, fail to disclose the risks
associated with the use of Gleevec, and make unsubstantiated dosing claims about
this medication that can put patients at higher risk of experiencing serious
adverse events." Reuters
(5/5) also covers the
story.
NYTimes praises FDA's efforts to reduce conflicts of interest.
The New
York Times (5/5, A30) editorializes, "The Food and Drug Administration
relies on 49 expert committees to advise it on policy matters and on whether
particular drugs or other medical products are safe and effective. The agency
has made substantial progress in reducing conflicts of interest among members,
and it is now pledging to search 'far and wide' for neutral experts and to make
more information public about any waivers it grants." Just last month, FDA
commissioner Dr. Margaret Hamburg urged staff members "to find experts without
any potential conflicts, and to justify any proposed waivers by describing how
hard they had looked for neutral specialists with equal expertise." According
to the Times, "That is all good news, provided the agency remains appropriately
stingy in granting waivers" to potential committee
members.
Employment/Workplace Safety
EEOC moves to refute Kelley Drye's defense in age discrimination suit.
The New
York Law Journal (5/5, Raymond) reports, "The Equal Employment
Opportunity Commission moved Monday to strike portions of the defense Kelley
Drye & Warren has put forward in the agency's age discrimination suit against
the firm." The EEOC "in January sued claiming Kelley Drye's compensation
practices discriminate against partners over 70 and that the firm retaliated
against the de-equitized partner who complained, Eugene T. D'Ablemont, by
slashing his 2008 bonus." In response to Kelley Drye's defense, the EEOC argues
that there is no statute of limitations on the suit, and that "any allegation
that D'Ablemont, in his role as a partner, had waived his right to sue Kelley
Drye under a federal anti-discrimination statute does not stop the EEOC from
bringing an action on his
behalf."
Complete Immunity Preemption
Pfeiffer criticizes lobbyists' efforts to preempt state financial regulations.
In the Huffington
Post (5/4), White House Communications Director Dan Pfeiffer presented
a list of "the Top Ten Most Wanted Lobbyist Loopholes" in the financial reform
legislation now before the Senate. At number four, he mentions, "Citing the
doctrine of 'preemption,' big banks will try to take away states' ability to
supplement federal consumer protections. Why is this a problem? Because state
officials are often the first to learn of new abuses and new problems in the
marketplace, and we should not get rid of that canary in the coal
mine."
Product Safety
Nissan recall to address potential Infiniti air bag problems.
The AP
(5/5) reports Nissan yesterday said the company "will recall nearly 135,000
Infiniti G35 sedans and coupes to address a problem that could lead to the air
bag not deploying in a crash." Nissan "said the recall involves G35 Coupes from
the 2005 to 2007 model years and G35 Sedans from the 2005 to 2006 model year."
The NHTSA said the company "had not yet provided the agency with a plan to fix
the
vehicles."
Also in the News
New York lawyer Rondos sentenced for stealing from clients.
The AP
(5/4) reported, "A disbarred New York lawyer is headed to prison for stealing
money he was supposed to manage for incapacitated children, mental patients and
elderly people. Steven Rondos was sentenced today in a Manhattan court to five
to 15 years in prison." Some of Rondos' victims "were medical malpractice
victims who had won money in
lawsuits."
|
|
AAJ News Brief is a digest of the most important news selected from thousands of
sources by the editors of Custom Briefings. The presence of advertising does not
endorse, or imply endorsement of, any products or services by the American
Association for
Justice.
This complimentary copy of AAJ News Brief was sent to haytham@puckettfaraj.com as part of your
American Association for Justice membership. View Custom Briefings' privacy policy. Neither
Custom Briefings nor the American Association for Justice is liable for the use
of or reliance on any information contained in this
briefing.
For information about other member benefits, please contact American Association
for Justice Member Service Center at (800)
424-2727.
American Association for Justice | 777 6th Street, NW | Washington, DC 20001
Copyright © 2010 by Custom Briefings
|
11190 Sunrise Valley Drive, Suite 130 | Reston, VA 20191
|
|